Effects of Ranitidine on Gastric Vesicles Containing H⁺, K⁺-Adenosine Triphosphatase in Rats

References

• Saunders J HB, Wormsley KG. Long-term effects and aftereffects of treatment of duodenal ulcer with metiamide. Lancet 1977; 1: 765–7
   PubMed Web of Science ®Google Scholar
• Nwokolo C U, Smith J TL, Pounder RE. Rebound intragastric hyperacidity after acute withdrawal of cimetidine, famotidine, or nizatidine is not mediated by persisting hypergastrinaemia. Gut 1989; 30: A725
   Web of Science ®Google Scholar
• Fullarton G M, Mc Lauchlan G, Mac Donald A, Crean G P, McColl KE. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut 1989; 30: 449–54
   PubMed Web of Science ®Google Scholar
• El Prewett, Hudson M, Kwokolo C U, Sawyerr A M, Pounder RE. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology 1991; 100: 873–7
   PubMed Web of Science ®Google Scholar
• Nwokolo C U, Smith J TL, Sawyerr A M, Pounder RE. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2receptor blockade. Gut 1991; 32: 1455–60
   PubMed Web of Science ®Google Scholar
• Witzel L, Halter F, Olah A J, Häcchl WH. Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat. Gastroenterology 1977; 73: 797–803
   PubMed Web of Science ®Google Scholar
• Kohn A, Annibale B, Prantera C, Giglio L, Suriano G, Delle Fave G. Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists. J Clin Gastroenterol 1991; 13: 284–90
   PubMed Web of Science ®Google Scholar
• Frislid K, Aadland E, Berstad A. Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. Sand J Gastroenterol 1986; 21: 119–22
   PubMed Web of Science ®Google Scholar
• Jones D B, Howden C W, Burget D W, Silletti C, Hunt RH. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist. Gut 1988; 29: 890–3
   PubMed Web of Science ®Google Scholar
• Chiverton S G, Hunt RH. Initial therapy and relapse of duodenal ulcer: Possible acid secretory mechanisms. Gastroenterology 1989; 96: 632–9
   PubMed Web of Science ®Google Scholar
• Lee J, Simpson G, Scholes P. An ATPase from dog gastric mucosa: Changes of outer pH in suspensions of membrane vesicles accompanying ATP hydrolysis. Biochem Biophys Res Commun 1974; 60: 825–32
   PubMed Web of Science ®Google Scholar
• Sachs G, Chang H H, Rabon E, Schackmann R, Lewin M, Saccomani G. A nonelectrogenic H+ pump in plasma membranes of hog stomach. J Biol Chem 1976; 251: 7690–8
   PubMed Web of Science ®Google Scholar
• Chang H, Saccomani G, Rabon E, Schackmann R, Sachs G. Proton transport by gastric membrane vesicles. Biochim Biophys Acta 1977; 464: 313–27
   PubMedGoogle Scholar
• Smolka A, Helander H F, Sachs G. Monoclonal antibodies against gastric H +, K+ ATPase. Am J Physiol 1983; 245: G589–96
   Google Scholar
• Ito S. The endoplasmic reticulum of gastric parietal cells. J Biophys Biochem Cytol 1961; 11: 333–47
   PubMedGoogle Scholar
• Saccomani G, Stewart H B, Shaw D, Lewin M, Sachs G. Characterization of gastric mucosal membranes. IX. Fractionation and purification of K+-ATPase-containing vesicles by zonal centrifugation and free-flow electrophoresis technique. Biochim Biophys Acta 1977; 465: 311–30
   PubMedGoogle Scholar
• Ljungström M, Norberg L, Olaisson H, Wernstedt C, Vega F V, Arvidson G. Characterization of proton-transporting membranes from resting pig gastric mucosa. Biochim Biophys Acta 1984; 769: 209–19
   PubMed Web of Science ®Google Scholar
• Vial J D, Orrego H. Electron microscopic observations on the fine structure of parietal cells. J Biophys Biochem Cytol 1960; 7: 367–72
   PubMedGoogle Scholar
• Helander H F, Hirschowitz BI. Quantitative ultrastructural studies on gastric parietal cells. Gastroenterology 1972; 63: 951–61
   PubMed Web of Science ®Google Scholar
• Ito S, Schofield GC. Studies on the depletion and accumulation of microvilli and changes in the tubulovesicular compartment of mouse parietal cells in relation to gastric acid secretion. J Cell Biol 1974; 63: 364–82
   PubMed Web of Science ®Google Scholar
• Ito S. Functional gastric morphology. Physiology of the gastrointestinal tract. Vol 1, L R Johnson. Raven Press, New York 1981; 37–50
   Google Scholar
• Forte J G, Black J A, Forte T M, Machen T E, Wolosin JM. Ultrastructural changes related to functional activity in gastric oxyntic cells. Am J Physiol 1981; 241: G349–58
   PubMedGoogle Scholar
• Gibert A J, Hersey SJ. Morphometric analysis of parietal cell membrane transformations in isolated gastric glands. J Membr Biol 1982; 67: 113–24
   PubMed Web of Science ®Google Scholar
• Jirón C, Romano M, Michelangeli F. A study of dynamic membrane phenomena during the gastric secretory cycle: fusion, retrieval and recycling of membranes. J Membr Biol 1984; 80: 119–34
   PubMed Web of Science ®Google Scholar
• Vial J V, Garrido J, González A. The early changes of parietal cell structure in the course of secretory activity in the rat. Am J Anat 1985; 172: 291–306
   PubMedGoogle Scholar
• Wolosin J M, Forte JG. Changes in the membrane environment of the (K+ + H+)-ATPase following stimulation of the gastric oxyntic cell. J Biol Chem 1981; 256: 3149–52
   PubMed Web of Science ®Google Scholar
• Im W B, Blakeman D P, Fieldhouse J M, Rabon EC. Effect of carbachol or histamine stimulation on rat gastric membranes enriched in (H+-K+)-ATPase. Biochim Biophys Acta 1984; 772: 167–75
   PubMedGoogle Scholar
• Hervatin F, Benkouka F, Robert J C, Peranzi G, Soumarmon A. The ontogeny of rat gastric H+/K+-ATPase. Biochim Biophys Acta 1989; 985: 320–24
   PubMedGoogle Scholar
• Crothers JM, Jr, Reenstra W W, Forte JG. Ontogeny of gastric H+K+-ATPase in suckling rabbits. Am J Physiol 1990; 22: G913–21
   Google Scholar
• Kubo K, Uehara A, Kubota T, Shaku F, Yamagata K, Toniguchi Y, et al. Effects of the histamine H2-receptor antagonist ranitidine on gastric vesicles containing the H+, K+-ATPase in rats. Gastroenterology 1994; 106: A820
   Web of Science ®Google Scholar
• Suzuki H, Obara M, Kubo K, Kanazawa T. Changes in the steady-state fluorescence anisotropy of N-iodoacetyl-N'-(5-sulfo-1-naphthyl) ethylenediamine attached to the specific thiol of sarcoplasmic reticulum Ca2+-ATPase throughout the catalytic cycle. J Biol Chem 1989; 264: 920–7
   PubMed Web of Science ®Google Scholar
• Kubo K, Suzuki H, Kanazawa T. Characterization of the substrate-induced conformational change of N-iodoacetyl-N'-(5-sulfo-1-naphthyl) ethylenediamine-labeled sarcoplasmic reticulum Ca2+-ATPase by using different kinds of substrate. Biochim Biophys Acta 1990; 1040: 251–9
   PubMedGoogle Scholar
• Martin J B, Doty DM. Determination of inorganic phosphate. Modification of isobutyl alcohol procedure. Anal Chem 1949; 21: 965–7
   Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Rabon E, Gunther R D, Soumarmon A, Bassilian S, Lewin M, Sachs G. Solubilization and reconstitution of the gastric H, K-ATPase. J Biol Chem 1985; 260(10)200–7
   Google Scholar
• Takaya J, Omori K, Taketani S, Kobayashi Y, Tashiro Y. Solubilization, purification, and characterization of (H+, K+) ATPase from hog gastric microsomes. J Biochem (Tokyo) 1987; 102: 903–11
   PubMed Web of Science ®Google Scholar
• Maeda M, Tagaya M, Futai M. Modification of gastric (H+ + K+)-ATPase with pyridoxal 5′-phosphate. J Biol Chem 1988; 263: 3652–6
   PubMed Web of Science ®Google Scholar
• Ganser A L, Forte JG. K+-stimulated ATPase in purified microsomes of bullfrog oxyntic cells. Biochim Biophys Acta 1973; 307: 169–80
   PubMed Web of Science ®Google Scholar
• Blom H. Cimetidine and parietal cell regeneration in experimental wounds in rat gastric mucosa. A light and electron microscopic study. Scand J Gastroenterol 1983; 18: 853–7
   PubMed Web of Science ®Google Scholar
• Deane S A, Grierson JM. The effect of cimetidine on chronic gastric ulcers in rats. Aust NZJ Surg 1988; 58: 147–52
   PubMedGoogle Scholar
• K-Åström M Jönsson, Bodemar G, Norrby K. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Sand J Gastroenterol 1988; 23: 433–41
   PubMed Web of Science ®Google Scholar
• Spurling N W, Selway S AM, Poynter D. An evaluation of the safety of ranitidine during seven years daily oral administration to beagle dogs. Human Toxicol 1989; 8: 23–32
   PubMedGoogle Scholar
• Helander H F, Mattsson H, Elm G, Ottosson S. Structure and function of rat parietal cells during treatment with omeprazole, SCH 28080, SCH 32651, or ranitidine. Scand J Gastroenterol 1990; 25: 799–809
   PubMed Web of Science ®Google Scholar
• Helander H F, Simonsson M, Sundler F, Rutgersson K, Helander KG. Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists. Virchows Arch Pathol Anat 1990; 417: 305–9
   Google Scholar
• Black J A, Forte T M, Forte JG. Inhibition of HCI secretion and the effects on ultrastructure and electrical resistance in isolated piglet gastric mucosa. Gastroenterology 1981; 81: 509–19
   PubMed Web of Science ®Google Scholar
• Helander H F, Sundell GW. Ultrastructure of inhibited parietal cells in the rat. Gastroenterology 1984; 87: 1064–71
   PubMed Web of Science ®Google Scholar
• Ainge G, Poynter D. H2 receptor antagonists. Ultrastructure of canine parietal cells after long term treatment with ranitidine. Scand J Gastroenterol 1982; 16: 143–54, Suppl 70
   Web of Science ®Google Scholar
• Fryklund J, Helander H F, Elander B, Wallmark B. Function and structure of parietal cells after H+-K+-ATPase blockade. Am J Physiol 1988; 254: G399–407
   Google Scholar
• Nielsen H O, Madsen P ER, Christiansen LA. The parietal cells in duodenal ulcer patients. A quantitative ultrastructural study before and during treatment with cimetidine. Scand J Gastroenterol 1980; 15: 793–7
   PubMed Web of Science ®Google Scholar
• Tari A, Yamamoto G, Sumii K, Sumii M, Takehara Y, Haruma K, et al. Role of histamine2 receptor in increased expression of rat gastric H+-K+-ATPase a-subunit induced by omeprazole. Am J Physiol 1993; 265: G752–8
   PubMedGoogle Scholar
• Feldman M, Burnton M. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. I. N Engl J Med 1990; 323: 1672–80
   PubMed Web of Science ®Google Scholar
• Crothers JM, Jr, Chow D C, Forte JG. Omeprazole decreases H+-K+-ATPase protein and increases permeability of oxyntic secretory membranes in rabbits. Am J Physiol 1993; 265: G231–41
   Google Scholar
• Wallmark B, Larsson H, Humble L. The relationship between gastric acid secretion and H+, K+-ATPase activity. J Biol Chem 1985; 260(13)681–4
   Google Scholar
• Wallmark B, Briving C, Fryklund J, Munson K, Jackson R, Mendlein J, et al. Inhibition of gastric H+, K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl (1, 2a) imidazole. J Biol Chem 1987; 262: 2077–84
   PubMed Web of Science ®Google Scholar
• Larsson H, Carlsson E, Ryberg B, Fryklund J, Wallmark B. Rat parietal cell function after prolonged inhibition of gastric acid secretion. Am J Physiol 1988; 254: G33–9
   PubMedGoogle Scholar
• Campbell V M, Yamada T. Effect of omeprazole on gene expression in canine gastric parietal cells. Am J Physiol 1991; 260: G434–9
   Google Scholar
• Tari A, Wu V, Sumii M, Sachs G, Walsh JH. Regulation of gastric H+/K+-ATPase a-subunit mRNA by omeprazole. Biochim Biophys Acta 1991; 1129: 49–56
   PubMedGoogle Scholar
• Swarovsky B, Eissele R, Gross M, Körtner G, Koop H, Arnold R, et al. Expression of the gastric H+/K+-ATPase and histidine decarboxylase during omeprazole treatment. Digestion 1994; 55: 97–102
   PubMed Web of Science ®Google Scholar
• Smolka A, Sachs G, Lorentzon P. Cell-free synthesis of rat and rabbit gastric proton pump. Gastroenterology 1989; 97: 873–81
   PubMed Web of Science ®Google Scholar
• Karam S M, Forte JG. Inhibiting gastric H+-K+-ATPase activity by omeprazole promotes degeneration and production of parietal cells. Am J Physiol 1994; 266: G745–58
   Google Scholar
• Morii M, Takata H, Fujisaki H, Takeguchi N. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18–5364 to inhibit gastric H+, K+-ATPase is correlated with the rate of acid-activation of the inhibitor. Biochem Pharmacol 1990; 39: 661–7
   PubMed Web of Science ®Google Scholar
• Lind T, Cederberg C, Ekenved G, Haglund O, Olbe L. Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270–6
   PubMed Web of Science ®Google Scholar
• Sharma B K, Walt R P, Pounder R E, Gomes M D, Wood E C, Logan LH. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984; 25: 957–64
   PubMed Web of Science ®Google Scholar
• Im W B, Blakeman D P, Davis JP. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole. Biochem Biophys Res Commun 1985; 126: 78–82
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Rune S J, Bytzer P, Kelbaek H, Jensen K G, Rask-Madsen J, et al. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. N Engl J Med 1985; 312: 958–61
   PubMed Web of Science ®Google Scholar
• Dahlgren S, Domellöf L, Hradsky M, Norryd C, Brunkwall J, Svensson G, et al. The effects of omeprazole and cimetidine on duodenal ulcer healing and the relief of symptoms. Aliment Pharmacol Ther 1988; 2: 483–92
   PubMedGoogle Scholar
• Hui W-M, Lam S-K, Lau W-Y, Branicki F J, Lok A S, Ng M M, et al. Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment. J Gastroenterol Hepatol 1989; 4: 35–43, Suppl 2
   PubMedGoogle Scholar